⌕
Teva- Pharmaceutical Industries · TEVA · NYSE
Tenet 34 · Weak
Compare
$44.50+1.95%At closeTenet 34 · Weak
$44.50+0.85 (+1.95%)
At close: Nov 13, 2026, 4:00 PM ET· NYSE · USD
$44.76+0.26 (+0.58%)
Pre-market: Nov 16, 2026, 8:03 AM ET· last 1-minute bar

Teva- Pharmaceutical Industries (TEVA) Stock

Teva- Pharmaceutical Industries (TEVA) closed at $44.50 on Nov 13, 2026; its Tenet Score is 34 of 100 against 297 Healthcare peers.

Sources Company filings, market prices and computed by Tenet Filings, prices and TenetScore as of How we compute thisNot investment advice

23 figures withheld by our checks. Each blank figure names its reason.

Key stats

Previous close
$44.50
Nov 13, 2026
Market cap
$51.9B
share price × the latest quarter's diluted weighted-average share count (vendor)
P/E
103.8×
price ÷ earnings
Tenet Score
34/100
Weak · 297 Healthcare peers

Industry: Drugs

Teva- Pharmaceutical Industries Ltd. scores 34/100. Weak. Financial health is the soft spot, trading at 104× earnings versus 297 Healthcare peers.

Tenet Score · vs sector

n=297
34/ 100
Weak
Fundamental composite — rates the business, not the timing.
Each metric's standing vs the company's own record is shown on the Statistics tab.
Value
24
Quality
56
Health
6
Growth
50

Factor grades

Grid rings: 25 · 50 · 75 · 100 percentile
Momentum omitted — no data yet.
ValueFQualityCHealthFGrowthCMomentum—
A grade is a label over the shown score. Value/Quality/Health/Growth are sector percentiles; Momentum ranks 12−1 return across the equity universe — a lens, never folded into the Tenet Score.
Show the math →

Price

Loading chart…
P/B
6.5×
price to book value
P/S
3.0×
price to fiscal 2025 sales
ROE
7%
return on equity
Operating margin
12.5%
fiscal 2025, before interest and tax
Net margin
3.0%
of revenue kept
Current ratio
0.95
current assets to liabilities
Net debt / EBITDA
5.2×
leverage, net of cash
EPS CAGR 5y
—
This growth figure starts in a period outside the history your plan includes.
Div yield
—
no yield on file
52-wk range
—
no 52-week range on file

The whole report, at a glance · every card is a live peek, click any to open the section

About Teva- Pharmaceutical Industries Ltd.

Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers steri…

Composite computed Nov 13, 2026 · peer basis: Healthcare (n=297) · every glimpse links to its full section with sources · not investment advice.

ETF exposure

held by 78 US ETFs · top wrappers by weightSee all ETFs holding TEVA →

Similar-sized companies in Drugs

The 10 companies in this industry closest in market cap, as of Nov 13, 2026.

CompanyTenet ScoreMarket cap
Moderna IncMRNA33$90.4B
Takeda Pharmaceutical CoTAK32$73.9B
Argen X SEARGX71$59.4B
Idexx Laboratories, Inc.IDXX52$55.5B
BeOne Medicines LtdONC64$47.6B
Biogen IncBIIB39$37.5B
Revolution Medicines IncRVMD39$37.3B
Zoetis IncZTS59$34.1B
Illumina IncILMN51$31.3B
Roivant Sciences LtdROIV42$28.6B

Compare Teva- Pharmaceutical Industries with

What sector and industry is Teva- Pharmaceutical Industries in?

Teva- Pharmaceutical Industries is in the Healthcare sector and the Drugs industry.

What is Teva- Pharmaceutical Industries' Tenet Score?

Teva- Pharmaceutical Industries' Tenet Score is 34 out of 100, ranked against 297 Healthcare peers as of Nov 13, 2026.

Install Tenet on your phone

Tenet home pageMethodology© 2026 Tenet Investing Inc.

Data from Intrinio and Financial Modeling Prep.